FLT3 ligand
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for FLT3 ligand, covering 2023-07-17 to 2025-08-13. Get the full timeline:
Most recent: Clinical Trial Update: CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer [Phase 1]